Key facts
- This page summarizes Johna Norton's Form 4 filing for ELI LILLY & Co (LLY).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 03 Jun 2024, 16:14.
Johna Norton - 03 Jun 2024 Form 4 Insider Report for ELI LILLY & Co (LLY)
- Reporting relationship
- EVP, Global Quality
- Issuer ticker
- LLY
- Reported as of
- 03 Jun 2024
- Net transaction value
- -$5,781,545
- SEC form
- 4
- Accepted by SEC
- 03 Jun 2024, 16:14:23 UTC
- Prior SEC filing
- 14 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jonathan Groff for Johna Norton, pursuant to authorization on file
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Johna Norton filed Form 4 for ELI LILLY & Co (LLY) on 03 Jun 2024.
Change
- Previous filing in this sequence was filed on 14 Feb 2024.
- Current net transaction value: -$5,781,545.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LLY
transaction
Common Stock
Sale
- Transaction value
- $5,781,545
- Shares
- -7,056
- Change %
- -22%
- Price
- $819.38
- Shares after
- 25,428
- Date
- 03 Jun 2024
- Ownership
- Direct
- Footnotes
- F1, F2
LLY
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 402
- Date
- 03 Jun 2024
- Ownership
- 401(k)
LLY
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,770
- Date
- 03 Jun 2024
- Ownership
- 401(k) - by partner
- Footnotes
- F3
LLY
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 128
- Date
- 03 Jun 2024
- Ownership
- by partner
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 3 footnotes
Footnote F1
The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2024.
Footnote F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $818.80 to $819.59, inclusive. The reporting person undertakes to provide to Eli Lilly and Company, any security holder of Eli Lilly and Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F3
The reporting person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein.